0001493152-23-043017.txt : 20231129 0001493152-23-043017.hdr.sgml : 20231129 20231129122604 ACCESSION NUMBER: 0001493152-23-043017 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231129 DATE AS OF CHANGE: 20231129 EFFECTIVENESS DATE: 20231129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bone Biologics Corp CENTRAL INDEX KEY: 0001419554 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 421743430 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-498325 FILM NUMBER: 231450286 BUSINESS ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 552-4452 MAIL ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Bone Biologics, Corp. DATE OF NAME CHANGE: 20140924 FORMER COMPANY: FORMER CONFORMED NAME: AFH ACQUISITION X, INC. DATE OF NAME CHANGE: 20071127 D 1 primary_doc.xml X0708 D LIVE 0001419554 Bone Biologics Corp 2 BURLINGTON WOODS DRIVE STE 100 BURLINGTON MA MASSACHUSETTS 01803 (781) 552-4452 DELAWARE AFH Acquisition X, Inc. Bone Biologics, Corp. AFH ACQUISITION X, INC. Corporation true Jeffrey Frelick 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Executive Officer Chief Executive Officer Deina H. Walsh 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Executive Officer Chief Financial Officer Don R. Hankey 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Director Bruce Stroever 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Director Erick Lucera 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Director Siddhesh Angle 2 Burlington Woods Drive Ste 100 Burlington MA MASSACHUSETTS 01803 Director Biotechnology Decline to Disclose 06b false 2023-11-16 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE 3RD FLOOR NEW YORK NY NEW YORK 10022 CA CALIFORNIA IL ILLINOIS NY NEW YORK false 729000 729000 0 Represents aggregate exercise proceeds that may be received upon exercise of warrants to purchase up to 1,139,063 shares at an exercise price of $0.64 per share. false 4 51030 0 Comprised of a total cash fee equal to 7.0% of the aggregate gross proceeds of the offering. The issuer also issued to placement agent or its designees warrants to purchase up to 68,344 shares at an exercise price of $0.80 under Section 4(a)(2). 0 false Bone Biologics Corp /s/ Jeffrey Frelick Jeffrey Frelick Chief Executive Officer 2023-11-29